Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
about
Targeting Protein-Protein Interactions in the HIF SystemHypoxia and fibrosis in chronic kidney disease: crossing at pericytesSmall-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1αTargeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α InteractionInhibition of 2-oxoglutarate dependent oxygenasesPotent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibitionNatural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.Manipulating angiogenesis in medicine.Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury.Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regenerationHypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury.Targeting carbonic anhydrase IX activity and expression.(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.Tuning the strength of a bacterial N-end rule degradation signalInhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice.Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.
P2860
Q26753176-414EA40F-C8BA-4355-92C6-A163ECF15C08Q26860894-8AE41F9E-749D-48D1-ACDA-A3C0458C206FQ27674529-7CBA6B79-816C-4FBD-92A3-53098A3E9239Q27677509-9DEBD2F9-B388-413F-A298-EC4F0D864270Q28306956-CCE7885A-D069-4711-B2D5-C346E664E170Q28822022-A393E7FB-EFBB-495A-A50A-422D10BDA067Q34009713-4CC74951-7743-48FA-8ED7-6740984B90C1Q34718191-505F6964-647E-49A6-B68C-E575541F8DF2Q35743851-0A59DB36-9536-4A03-B86A-12D8DA126957Q35758445-31BD310A-906E-493A-A0E7-30DCBB77F59FQ36316659-1DF6E043-FE77-451A-BED9-86C2ECD943E0Q36392988-2BB0702A-C18E-4DBB-AF6E-5EC2879F04F0Q36753387-390936CA-FA15-4887-9529-D9A9994A823FQ36980763-38844293-B2D8-4355-8BC7-36B75B62E032Q37164162-4104B6D8-B3C5-4D86-8FFD-1A51C96E324EQ38342634-17A3A262-C62E-4B16-AA18-A9681D83DEBBQ42082584-0EDA1E3B-E940-4C9A-AC0E-0B85B0351795Q42426520-970E06D5-6E6E-43EE-962F-7EEB89EB6EB2Q45023553-47251E4A-C546-4A6D-BE9C-D821B1077791Q46313125-6667D887-3F82-4789-AEDD-6B2CFB51F457Q46905324-22C781AF-46B0-4DA9-BDE8-5A0F043292FC
P2860
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@ast
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@en
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@nl
type
label
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@ast
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@en
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@nl
prefLabel
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@ast
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@en
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@nl
P2093
P2860
P356
P1476
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis
@en
P2093
Carsten Willam
Christopher W Pugh
Kai-Uwe Eckardt
Michael I Wilson
Norma Masson
Patrick H Maxwell
Roy Bicknell
S Aleema Mahmood
P2860
P304
10423-10428
P356
10.1073/PNAS.162119399
P407
P577
2002-07-29T00:00:00Z